研究業績
-
2024年01月04日Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment.
-
2024年01月04日Clonal identification and Characterization of self-renewing pluripotent stem cells in the developing liver.
-
2024年01月04日造血幹細胞の可塑性
-
2024年01月04日再生医学が分かる 第4章 組織幹細胞の可塑性と再生医学
-
2024年01月04日The simplified retroviral vector GCsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in NOD/SCID mice.
-
2024年01月04日Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7.
-
2024年01月04日Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.
-
2024年01月04日造血細胞の遺伝子治療
-
2021年11月24日2021-11：iPS細胞を使った “off-the-shelf” CAR-T細胞の開発
-
2021年05月17日2021-6：Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells
-
2020年12月18日2020-1：Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling.
-
2020年03月04日2020-3：Non-clinical efficacy, safety, and stable clinical cell processing of iPSC-derived anti-GPC3 CAR-expressing NK/ILC cells.
